The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

Hi, it's Amber in Hong Kong. Blockbuster weight-loss drug Wegovy is going to be much cheaper in China than it is in the US.

The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...

Ozempic is approved only for treating Type 2 diabetes but claims about its weight-loss powers have seen demand soar, ...

For years, Miriam Schulman of Highland Park, New Jersey, struggled with what she called ‘food noise.’ “You’re always thinking ...

Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles ...

Ozempic has been a hot topic in Hollywood with stars either admitting to using the diabetes drug for weight loss or staunchly ...

As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.

The efforts by Eli Lilly and Novo Nordisk could be a game-changer for sales, which some analysts say could exceed $100 ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

The COVID pandemic set in motion trends with alcohol use that have persisted. Disruptions in work, school and lifestyle have ...